Botulinum Toxin in Migraine Treatment
Loading...
Date
Journal Title
Journal ISSN
Volume Title
dc.identifier.issn
dc.identifier.doi
10.4274/npa.y7198
dc.identifier.other
dc.description.volume
50
dc.description.issue
1
Publisher
TURKISH NEUROPSYCHIATRY ASSOC-TURK NOROPSIKIYATRI DERNEGI
DOI
10.4274/npa.y7198
Abstract
Since botulinum toxin might have a therapeutic effect on pain, many studies investigating the efficiency of botulinum toxin in headache treatment have been done. The most satisfying results were achieved by botulinum toxin type A (BoNT/A) in the treatment of chronic migraine. In this paper, we reviewed the clinical effectiveness of BoNT/A in migraine and included our clinical experience. In our ongoing pilot study, where we have repeated BoNT/A injections every 12 weeks, The difference in the Migraine Disability Assessment (MIDAS) scores between the first and the second injections was 61.1\%
and between the first and the 3rd injections was found to be 65.72\%.
and between the first and the 3rd injections was found to be 65.72\%.
